Safety and predictors of a positive result of intracoronary ergonovine testing in patients with ischemic heart disease without hemodynamically significant coronary artery stenosis in Taiwan

Acta Cardiologica Sinica

Volumn 23, Issue 3, 2007, Pages 150-159

  Hung, Ming Yow ^a,b   Hung, Ming Jui ^a,b   Cheng, Chi Wen ^a   Yang, Ning I ^a   Cherng, Wen Jin ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Coronary vasospasm; Ergonovine; Ventricular fibrillation

Indexed keywords

ERGOMETRINE; GLYCERYL TRINITRATE; METHYLERGOMETRINE MALEATE;

ADULT; AGED; ANGINA PECTORIS; ARTERY DIAMETER; ARTICLE; BODY MASS; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY SPASM; DRUG FATALITY; DRUG SAFETY; FEMALE; HEART INFARCTION; HEART VENTRICLE FIBRILLATION; HEMODYNAMICS; HUMAN; INTRACORONARY INFUSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROVOCATION TEST; RISK ASSESSMENT; SMOKING; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; TAIWAN;

EID: 36549007610     PISSN: 10116842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Hung MJ, Cheng CW, Yang NI, et al. Coronary vasospasm-related acute coronary syndrome complicated by life-threatening cardiac arrhythmias in patients without hemodynamically significant coronary artery disease. Int J Cardiol 2007;117:37-44.
2. Hung MJ, Cherng WJ, Kuo LT, et al. Acute myocardial infarction in Taiwanese with angiographically normal coronary arteries: role of coronary artery spasm. Acta Cardiol Sin 2003;19:31-8.
3. Waters DD, Szlachcic J, Miller D, et al. Clinical characteristics of patients with variant angina complicated by myocardial infarction or death within 1 month. Am J Cardiol 1982;49:658-64.
4. Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 1999;33:1756-816.
5. Hackett D, Larkin S, Chierchia S, et al. Induction of coronary artery spasm by a direct local action of ergonovine. Circulation 1987;75:577-82.
6. Nosaka H, Nobuyoshi M. Coronary arterial spasm and symptomatology in ischemic and non-ischemic heart diseases: study of the ergonovine maleate provocative test in 3,000 consecutive patients. J Cardiol 1987;12(suppl):35-47.
7. Bertrand ME, LaBlanche JM, Tilmant PY, et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation 1982;65:1299-306.
8. Sueda S, Kohno H, Fukuda H, et al. Frequency of provoked coronary spasms in patients undergoing coronary arteriography using a spasm provocation test via intracoronary administration of ergonovine. Angiology 2004;55:403-11.
9. Curry RC Jr, Pepine CJ, Sabom MB, et al. Effects of ergonovine in patients with and without coronary artery disease. Circulation 1977;56:803-9.
10. Buxton A, Goldberg S, Hirshfeld JW, et al. Refractory ergonovine-induced coronary vasospasm: importance of intracoronary nitroglycerin. Am J Cardiol 1980;46:329-34.
11. Harding MB, Leithe ME, Mark DB, et al. Ergonovine maleate testing during cardiac catheterization: a 10-year perspective in 3,447 patients without significant coronary artery disease or Prinzmetal's variant angina. J Am Coll Cardiol 1992;20:107-11.
12. Hung MJ, Cherng WJ, Yang NI, et al. Relation of high-sensitivity C-reactive protein level with coronary vasospastic angina pectoris in patients without hemodynamically significant coronary artery disease. Am J Cardiol 2005;96:1484-90.
13. Hung MJ, Cherng WJ, Cheng CW, et al. Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease. Am J Cardiol 2006;97:1429-34.
14. Beltrame JF, Sasayama S, Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. J Am Coll Cardiol 1999;33:1442-52.
15. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 1993;87:76-9.
16. Hung MJ, Kuo LT, Cheng CW, et al. Comparison of peripheral monocyte counts in patients with and without coronary spasm and without fixed coronary narrowing. Am J Cardiol 2004;93:620-4.
17. Baim DS, Grossman W. Coronary angiography. In: Baim DS, Grossman W, Eds. Grossman's Cardiac Catheterization, Angiography, and Intervention. 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2000;249.
18. Yasue H, Omote S, Takizawa A, et al. Comparison of coronary arteriographic findings during angina pectoris associated with S-T elevation or depression. Am J Cardiol 1981;47:539-46.
19. Sueda S, Kohno H, Fukuda H, et al. Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations. Coron Artery Dis 2004;15:491-7.
20. Wilhelmsen L, Wedel H, Tibblin G. Multivariate analysis of risk factors for coronary heart disease. Circulation 1973;48:950-8.
21. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project. The Pooling Project research group.("research group" doesn't need to capitalized.) J Chronic Dis 1978;31:201-306.
22. Neaton JD, Kuller LH, Wentworth D, Borhani NO. Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years. Am Heart J 1984;108:759-69.
23. Vlietstra RE, Kronmal RA, Frye RL, et al. Factors affecting the extent and severity of coronary artery disease in patients enrolled in the Coronary Artery Surgery Study. Arteriosclerosis 1982;2:208-15.
24. Olgin JE, Zipes DP. Specific arrhythmias: diagnosis and treatment. In: Zipes DP, Libby P, Bonow RO, Braunwald E, Eds. Heart Disease: A Textbook of Cardiovascular Medicine. 7th ed. Philadelphia: Saunders, 2005;853.
25. Lown B, Verrier RL. Neural activity and ventricular fibrillation. N Engl J Med 1976;294:1165-70.
26. Choquette G, Wasserman F, Lisker S, Bellet S. Spontaneous reversion of ventricular fibrillation to normal sinus rhythm in a case of acute myocardial infarction. Am Heart J 1956;51:455-9.
27. Patt MV, Podrid PJ, Friedman PL, Lown B. Spontaneous reversion of ventricular fibrillation. Am Heart J 1988;115:919-23.
28. Dubner SJ, Gimeno GM, Elencwajg B, et al. Ventricular fibrillation with spontaneous reversion on ambulatory ECG in the absence of heart disease. Am Heart J 1983;105:691-3.
29. Farmer DM, Swygman CA, Wang PJ, et al. Evidence that non-sustained polymorphic ventricular tachycardia causes syncope (data from implantable cardioverter defibrillators). Am J Cardiol 2003;91:606-9.
30. Deanfield JE, Shea MJ, Wilson RA, et al. Direct effects of smoking on the heart: silent ischemic disturbances of coronary flow. Am J Cardiol 1986;57:1005-9.
31. Maouad J, Fernandez F, Hebert JL, et al. Cigarette smoking during coronary angiography: diffuse or focal narrowing (spasm) of the coronary arteries in 13 patients with angina at rest and normal coronary angiograms. Cathet Cardiovasc Diagn 1986;12:366-75.
32. Ota Y, Kugiyama K, Sugiyama S, et al. Impairment of endothelium-dependent relaxation of rabbit aortas by cigarette smoke extract: role of free radicals and attenuation by Captopril. Atherosclerosis 1997;131:195-202.